摘要
慢性血栓栓塞性肺动脉高压(CTEPH)是肺栓塞的潜在致命结果。目前肺动脉内膜剥脱术(PEA)是首选的治疗方法,但多种因素限制了其临床应用和开展。对于不能行PEA治疗的CTEPH患者,经皮球囊肺动脉成形术是近年来发展迅速的一种能够改善患者临床症状、降低肺动脉压力和肺血管阻力并改善患者预后的新的介入治疗方法。
Chronic thromboembolic pulmonary hypertension(CTEPH)is a potentially lethal outcome of pulmonary embolism.At present,pulmonary endarterectomy(PEA)is the preferred treatment method for CTEPH,but many factors limit its clinical application and development.For CTEPH patients who can not be treated with PEA,percutaneous balloon pulmonary angioplasty(BPA)is a new interventional therapy developed rapidly in recent years,which can improve the clinical symptoms,reduce the pulmonary artery pressure and pulmonary vascular resistance of the patients,and improve their prognoses.
作者
洪城
陈海明
HONG Cheng;CHEN Hai-ming(State Key Laboratory of Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangdong 510010 China)
出处
《中国临床新医学》
2020年第9期869-873,共5页
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词
慢性血栓栓塞性肺动脉高压
肺动脉内膜剥脱术
经皮球囊肺动脉成形术
Chronic thromboembolic pulmonary hypertension(CTEPH)
Pulmonary endarterectomy(PEA)
Percutaneous balloon pulmonary angioplasty(BPA)
